Annual Retained Earnings
$7.12 B
-$107.47 M-1.49%
01 December 2023
Summary:
Sinovac Biotech annual retained earnings is currently $7.12 billion, with the most recent change of -$107.47 million (-1.49%) on 01 December 2023. During the last 3 years, it has risen by +$6.97 billion (+4835.15%). SVA annual retained earnings is now -1.49% below its all-time high of $7.23 billion, reached on 31 December 2022.SVA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$7.11 B
-$10.87 M-0.15%
01 June 2024
Summary:
Sinovac Biotech quarterly retained earnings is currently $7.11 billion, with the most recent change of -$10.87 million (-0.15%) on 01 June 2024. Over the past year, it has dropped by -$10.87 million (-0.15%). SVA quarterly retained earnings is now -6.77% below its all-time high of $7.62 billion, reached on 30 June 2022.SVA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -0.1% |
| 3 y3 years | +4835.1% | +35.4% |
| 5 y5 years | +10000.0% | +10000.0% |
SVA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.5% | +4835.1% | -6.8% | +35.4% |
| 5 y | 5 years | -1.5% | >+9999.0% | -6.8% | >+9999.0% |
| alltime | all time | -1.5% | >+9999.0% | -6.8% | >+9999.0% |
Sinovac Biotech Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $7.11 B(-0.2%) |
| Dec 2023 | $7.12 B(-1.5%) | $7.12 B(-1.7%) |
| June 2023 | - | $7.24 B(+0.2%) |
| Dec 2022 | $7.23 B(+1.2%) | $7.23 B(-5.2%) |
| June 2022 | - | $7.62 B(+6.7%) |
| Dec 2021 | $7.14 B(+4851.3%) | $7.14 B(+36.0%) |
| June 2021 | - | $5.25 B(+3539.5%) |
| Dec 2020 | $144.24 M(+154.3%) | $144.24 M(+168.3%) |
| Sept 2020 | - | $53.77 M(+21.9%) |
| June 2020 | - | $44.12 M(-10.6%) |
| Mar 2020 | - | $49.37 M(-13.0%) |
| Dec 2019 | $56.73 M(+138.2%) | $56.73 M(+35.3%) |
| Sept 2019 | - | $41.94 M(+17.6%) |
| June 2019 | - | $35.66 M(+42.6%) |
| Mar 2019 | - | $25.00 M(+5.0%) |
| Dec 2018 | $23.82 M(+160.8%) | $23.82 M(+2.6%) |
| June 2018 | - | $23.22 M(+154.2%) |
| Dec 2017 | $9.13 M(-176.6%) | $9.13 M(-960.7%) |
| June 2017 | - | -$1.06 M(-91.1%) |
| Dec 2016 | -$11.91 M(+19.4%) | -$11.91 M(-10.6%) |
| Sept 2016 | - | -$13.33 M(-19.4%) |
| June 2016 | - | -$16.53 M(+137.1%) |
| Mar 2016 | - | -$6.97 M(-30.1%) |
| Dec 2015 | -$9.98 M(+56.3%) | -$9.98 M(+25.3%) |
| Sept 2015 | - | -$7.96 M(+25.1%) |
| June 2015 | - | -$6.36 M(-26.3%) |
| Mar 2015 | - | -$8.63 M(+35.3%) |
| Dec 2014 | -$6.38 M(+35.4%) | -$6.38 M(-7.1%) |
| Sept 2014 | - | -$6.87 M(-1.3%) |
| June 2014 | - | -$6.96 M(+47.7%) |
| Mar 2014 | - | -$4.71 M(-0.1%) |
| Dec 2013 | -$4.71 M(-61.2%) | -$4.71 M(-55.3%) |
| Sept 2013 | - | -$10.54 M(-18.0%) |
| June 2013 | - | -$12.85 M(-9.3%) |
| Mar 2013 | - | -$14.16 M(+16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$12.16 M(-550.9%) | -$12.16 M(+77.0%) |
| Sept 2012 | - | -$6.87 M(+78.9%) |
| June 2012 | - | -$3.84 M(+31.6%) |
| Mar 2012 | - | -$2.92 M(-208.2%) |
| Dec 2011 | $2.70 M(-30.4%) | $2.70 M(+927.1%) |
| Sept 2011 | - | $262.50 K(-89.1%) |
| June 2011 | - | $2.40 M(-80.8%) |
| Mar 2011 | - | $12.55 M(+223.9%) |
| Dec 2010 | $3.88 M(-72.3%) | $3.88 M(-73.1%) |
| Sept 2010 | - | $14.43 M(-2.0%) |
| June 2010 | - | $14.73 M(+7.6%) |
| Mar 2010 | - | $13.69 M(-2.2%) |
| Dec 2009 | $13.99 M(-947.3%) | $13.99 M(+48.8%) |
| Sept 2009 | - | $9.41 M(+125.0%) |
| June 2009 | - | $4.18 M(-357.0%) |
| Mar 2009 | - | -$1.63 M(-1.5%) |
| Dec 2008 | -$1.65 M(-76.8%) | -$1.65 M(+11.9%) |
| Sept 2008 | - | -$1.48 M(-33.4%) |
| June 2008 | - | -$2.22 M(-60.1%) |
| Mar 2008 | - | -$5.55 M(-21.9%) |
| Dec 2007 | -$7.11 M(-45.0%) | -$7.11 M(-2.2%) |
| Sept 2007 | - | -$7.27 M(-23.1%) |
| June 2007 | - | -$9.46 M(-26.8%) |
| Dec 2006 | -$12.93 M(+11.9%) | -$12.93 M(+3.3%) |
| June 2006 | - | -$12.52 M(+8.4%) |
| Dec 2005 | -$11.55 M(+87.7%) | -$11.55 M(+20.1%) |
| June 2005 | - | -$9.62 M(+56.3%) |
| Dec 2004 | -$6.16 M(+769.5%) | -$6.16 M(+21.3%) |
| Sept 2004 | - | -$5.07 M(+41.0%) |
| June 2004 | - | -$3.60 M(+408.2%) |
| Dec 2003 | -$707.90 K(-33.4%) | -$707.90 K |
| Apr 2002 | -$1.06 M(+19.6%) | - |
| Apr 2001 | -$888.50 K(+120.0%) | - |
| Apr 2000 | -$403.90 K(+6113.8%) | - |
| Apr 1999 | -$6500.00 | - |
FAQ
- What is Sinovac Biotech annual retained earnings?
- What is the all time high annual retained earnings for Sinovac Biotech?
- What is Sinovac Biotech quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sinovac Biotech?
- What is Sinovac Biotech quarterly retained earnings year-on-year change?
What is Sinovac Biotech annual retained earnings?
The current annual retained earnings of SVA is $7.12 B
What is the all time high annual retained earnings for Sinovac Biotech?
Sinovac Biotech all-time high annual retained earnings is $7.23 B
What is Sinovac Biotech quarterly retained earnings?
The current quarterly retained earnings of SVA is $7.11 B
What is the all time high quarterly retained earnings for Sinovac Biotech?
Sinovac Biotech all-time high quarterly retained earnings is $7.62 B
What is Sinovac Biotech quarterly retained earnings year-on-year change?
Over the past year, SVA quarterly retained earnings has changed by -$10.87 M (-0.15%)